Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Flavonoid glycoside red yeast rice lovastatin and preparation method thereof

A flavonoid glycoside red yeast rice and lovastatin technology, applied in the direction of anti-toxic agents, medical raw materials derived from ginkgo biloba, blood diseases, etc., can solve the problem of difficulty in controlling the dosage of patients, functional red yeast rice extract and ginkgo leaf extract To achieve the effect of inhibiting platelet aggregation, protecting brain cells, and dilating coronary arteries

Inactive Publication Date: 2017-01-11
刘方旭
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, the process of taking functional red yeast extract and ginkgo leaf extract is cumbersome, especially for patients who are not easy to grasp the dosage; how to conveniently grasp the dosage of functional red yeast extract and ginkgo leaf extract and carry Convenience to take has become an urgent problem for patients with cardiovascular and cerebrovascular diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] ⑴Raw material components: 55% functional red yeast rice extract, 45% ginkgo biloba extract.

[0016] ⑵The process preparation steps are as follows: ① Mixing: put the raw material components into the V-type high-efficiency asymmetric mixer in proportion, and the stirring speed is 12 rpm.

[0017] The mixing time is 8 minutes, and the mixed powder is obtained;

[0018] ②Capsule making: Add the mixed powder into the capsule filling machine to make capsules with a mass of 0.5g each;

[0019] ③Sterilization packaging: Put the capsules under ultraviolet light for 5 minutes and pack them in time.

Embodiment 2

[0021] ⑴Raw material components: 57% functional red yeast rice extract, 43% ginkgo biloba extract.

[0022] ⑵The process preparation steps are as follows: ① Mixing: put the raw material components into the V-type high-efficiency asymmetric mixer in proportion, and the stirring speed is 12 rpm.

[0023] The mixing time is 9 minutes, and the mixed powder is obtained;

[0024] ②Capsule making: Add the mixed powder into the capsule filling machine to make capsules with a mass of 0.5g each;

[0025] ③Sterilization packaging: Put the capsules under ultraviolet light for 5 minutes and pack them in time.

Embodiment 3

[0027] ⑴Raw material components: 60% functional red yeast rice extract, 40% ginkgo biloba extract.

[0028] ⑵The process preparation steps are as follows: ① Mixing: put the raw material components into the V-type high-efficiency asymmetric mixer in proportion, and the stirring speed is 12 rpm.

[0029] The mixing time is 10 min, and the mixed powder is obtained;

[0030] ②Capsule making: Add the mixed powder into the capsule filling machine to make capsules with a mass of 0.5g each;

[0031] ③Sterilization packaging: Put the capsules under ultraviolet light for 5 minutes and pack them in time.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a flavonoid glycoside red yeast rice lovastatin and a preparation method thereof. The flavonoid glycoside red yeast rice lovastatin is prepared from 55-60% of functional red yeast rice extract and 40-45% of ginkgo leaf extract. The ginkgo leaf flavonoid glycoside composite red yeast rice lovastatin capsule prepared by mixing, capsulation and sterile packaging is convenient for the patient to carry about and convenient for mastering the dose, and is capable of avoiding generating cholesterol, increasing the cerebrovascular flow, lowering the cerebral vascular resistance, improving the cerebrovascular circulatory function, protecting the brain cells, protecting the patient from ischemic injuries, expanding the coronary artery, preventing angina pectoris and myocardial infarction, inhibiting the platelets from aggregation, preventing thrombosis, clearing away harmful oxyradicals and enhancing the immunological competence. The flavonoid glycoside red yeast rice lovastatin has expected curative effects on coronary heart disease, angina pectoris, cerebral arteriosclerosis, senile dementia, hypertension and other diseases.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine extracts, in particular to a flavonoid glycoside monascus lovastatin and a preparation method thereof. Background technique [0002] With the improvement of people's living standards, there are more and more patients with cardiovascular and cerebrovascular diseases, which has brought serious harm to the health of the people and seriously affected the life and work of patients. A large number of clinical epidemiological data show that cardiovascular and cerebrovascular diseases are a common disease that seriously threatens the health of human beings, especially middle-aged and elderly people over 50 years old. Survivors of cerebrovascular accidents cannot fully take care of themselves! The number of people who die from cardiovascular and cerebrovascular diseases in the world is as high as 15 million every year, ranking first among various causes of death. Cardiovascular and ce...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/16A61K9/48A61P7/02A61P9/10A61P9/12A61P25/28A61P39/06A61P37/04A61K31/47
Inventor 刘方旭
Owner 刘方旭
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com